Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hypertension in pregnancy].

R Cífková1

  • 1Pracoviste preventivní kardiologie IKEM, Praha. reci@medicon.cz

Vnitrni Lekarstvi
|May 26, 2006
PubMed
Summary

Hypertension in pregnancy, a leading cause of maternal and newborn mortality, requires careful management. Guidelines define hypertension using absolute blood pressure values, distinguishing between pre-existing and gestational conditions for appropriate treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypertensive complications of pregnancy: A clinical overview.

Metabolism: clinical and experimental·2017
Same author

Success and failure of cardiovascular disease prevention in Czech Republic over the past 30 years. Czech part of the EUROASPIRE I-IV surveys.

Physiological research·2017
Same author

ESHRE Guideline: management of women with premature ovarian insufficiency.

Human reproduction (Oxford, England)·2016
Same author

A comparison of secondary prevention practice in poststroke and coronary heart disease patients.

Public health·2016
Same author

Association of intima-media thickness of carotid arteries with remnant lipoproteins in men and women.

Physiological research·2015
Same author

Desphospho-uncarboxylated matrix Gla protein is associated with increased aortic stiffness in a general population.

Journal of human hypertension·2015

Area of Science:

  • Obstetrics and Gynecology
  • Cardiology
  • Maternal-Fetal Medicine

Context:

  • Hypertension in pregnancy is a significant global health concern, contributing to maternal and fetal morbidity and mortality.
  • Current European Society of Hypertension guidelines define hypertension based on absolute blood pressure values (systolic ≥ 140 mm Hg or diastolic ≥ 90 mm Hg).
  • Accurate classification distinguishing pre-existing from gestational hypertension is crucial for effective management.

Purpose:

  • To outline the diagnostic criteria for hypertension in pregnancy.
  • To delineate management strategies, including non-pharmacological and pharmacological interventions.
  • To specify treatment thresholds and drug choices for various hypertensive conditions during pregnancy.

Summary:

  • Hypertension in pregnancy is classified as pre-existing (diagnosed before or within 20 weeks of gestation) or gestational (pregnancy-induced).
  • Non-pharmacological interventions are considered for mild elevations (140-150/90-99 mm Hg), while severe cases (≥ 170/110 mm Hg) necessitate hospitalization.
  • Pharmacological treatment involves agents like labetalol, methyldopa, and nifedipine, with specific thresholds for initiation based on condition and comorbidities. ACE inhibitors and AT1 blockers are contraindicated.

Impact:

  • Provides clear guidelines for healthcare professionals managing hypertension in pregnancy.
  • Aims to reduce maternal and fetal complications associated with hypertensive disorders.
  • Emphasizes individualized treatment approaches based on hypertension type, severity, and patient factors.

Related Experiment Videos